210 related articles for article (PubMed ID: 27706259)
1. Augmented Growth Hormone Secretion and Stat3 Phosphorylation in an Aryl Hydrocarbon Receptor Interacting Protein (AIP)-Disrupted Somatotroph Cell Line.
Fukuda T; Tanaka T; Hamaguchi Y; Kawanami T; Nomiyama T; Yanase T
PLoS One; 2016; 11(10):e0164131. PubMed ID: 27706259
[TBL] [Abstract][Full Text] [Related]
2. A Novel Mutation of Aryl Hydrocarbon Receptor Interacting Protein Gene Associated with Familial Isolated Pituitary Adenoma Mediates Tumor Invasion and Growth Hormone Hypersecretion.
Cai F; Hong Y; Xu J; Wu Q; Reis C; Yan W; Wang W; Zhang J
World Neurosurg; 2019 Mar; 123():e45-e59. PubMed ID: 30447469
[TBL] [Abstract][Full Text] [Related]
3. STAT3 upregulation in pituitary somatotroph adenomas induces growth hormone hypersecretion.
Zhou C; Jiao Y; Wang R; Ren SG; Wawrowsky K; Melmed S
J Clin Invest; 2015 Apr; 125(4):1692-702. PubMed ID: 25774503
[TBL] [Abstract][Full Text] [Related]
4. The aging suppressor klotho: a potential regulator of growth hormone secretion.
Shahmoon S; Rubinfeld H; Wolf I; Cohen ZR; Hadani M; Shimon I; Rubinek T
Am J Physiol Endocrinol Metab; 2014 Aug; 307(3):E326-34. PubMed ID: 24939736
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin analogs modulate AIP in somatotroph adenomas: the role of the ZAC1 pathway.
Chahal HS; Trivellin G; Leontiou CA; Alband N; Fowkes RC; Tahir A; Igreja SC; Chapple JP; Jordan S; Lupp A; Schulz S; Ansorge O; Karavitaki N; Carlsen E; Wass JA; Grossman AB; Korbonits M
J Clin Endocrinol Metab; 2012 Aug; 97(8):E1411-20. PubMed ID: 22659247
[TBL] [Abstract][Full Text] [Related]
6. Mild pituitary phenotype in 3- and 12-month-old Aip-deficient male mice.
Lecoq AL; Zizzari P; Hage M; Decourtye L; Adam C; Viengchareun S; Veldhuis JD; Geoffroy V; Lombès M; Tolle V; Guillou A; Karhu A; Kappeler L; Chanson P; Kamenický P
J Endocrinol; 2016 Oct; 231(1):59-69. PubMed ID: 27621108
[TBL] [Abstract][Full Text] [Related]
7. Expression of Peroxisome Proliferator-Activated Receptor alpha (PPARα) in somatotropinomas: Relationship with Aryl hydrocarbon receptor Interacting Protein (AIP) and in vitro effects of fenofibrate in GH3 cells.
Rotondi S; Modarelli A; Oliva MA; Rostomyan L; Sanita P; Ventura L; Daly AF; Esposito V; Angelucci A; Arcella A; Giangaspero F; Beckers A; Jaffrain-Rea ML
Mol Cell Endocrinol; 2016 May; 426():61-72. PubMed ID: 26872613
[TBL] [Abstract][Full Text] [Related]
8. Epithelial splicing regulator protein 1 and alternative splicing in somatotroph adenomas.
Lekva T; Berg JP; Lyle R; Heck A; Ringstad G; Olstad OK; Michelsen AE; Casar-Borota O; Bollerslev J; Ueland T
Endocrinology; 2013 Sep; 154(9):3331-43. PubMed ID: 23825128
[TBL] [Abstract][Full Text] [Related]
9. Aip regulates cAMP signalling and GH secretion in GH3 cells.
Formosa R; Xuereb-Anastasi A; Vassallo J
Endocr Relat Cancer; 2013 Aug; 20(4):495-505. PubMed ID: 23702468
[TBL] [Abstract][Full Text] [Related]
10. Regulation of aryl hydrocarbon receptor interacting protein (AIP) protein expression by MiR-34a in sporadic somatotropinomas.
Dénes J; Kasuki L; Trivellin G; Colli LM; Takiya CM; Stiles CE; Barry S; de Castro M; Gadelha MR; Korbonits M
PLoS One; 2015; 10(2):e0117107. PubMed ID: 25658813
[TBL] [Abstract][Full Text] [Related]
11. Functional expression of CXCR4 in somatotrophs: CXCL12 activates GH gene, GH production and secretion, and cellular proliferation.
Lee Y; Kim JM; Lee EJ
J Endocrinol; 2008 Nov; 199(2):191-9. PubMed ID: 18753332
[TBL] [Abstract][Full Text] [Related]
12. The glucose-dependent insulinotropic polypeptide receptor is overexpressed amongst GNAS1 mutation-negative somatotropinomas and drives growth hormone (GH)-promoter activity in GH3 cells.
Occhi G; Losa M; Albiger N; Trivellin G; Regazzo D; Scanarini M; Monteserin-Garcia JL; Fröhlich B; Ferasin S; Terreni MR; Fassina A; Vitiello L; Stalla G; Mantero F; Scaroni C
J Neuroendocrinol; 2011 Jul; 23(7):641-9. PubMed ID: 21554434
[TBL] [Abstract][Full Text] [Related]
13. Metformin inhibits proliferation and growth hormone secretion of GH3 pituitary adenoma cells.
An J; Pei X; Zang Z; Zhou Z; Hu J; Zheng X; Zhang Y; He J; Duan L; Shen R; Zhang W; Zhu F; Li S; Yang H
Oncotarget; 2017 Jun; 8(23):37538-37549. PubMed ID: 28380462
[TBL] [Abstract][Full Text] [Related]
14. Prkar1a haploinsufficiency ameliorates the growth hormone excess phenotype in Aip-deficient mice.
Schernthaner-Reiter MH; Trivellin G; Roetzer T; Hainfellner JA; Starost MF; Stratakis CA
Hum Mol Genet; 2020 Oct; 29(17):2951-2961. PubMed ID: 32821937
[TBL] [Abstract][Full Text] [Related]
15. AIP mutations impair AhR signaling in pituitary adenoma patients fibroblasts and in GH3 cells.
Lecoq AL; Viengchareun S; Hage M; Bouligand J; Young J; Boutron A; Zizzari P; Lombès M; Chanson P; Kamenický P
Endocr Relat Cancer; 2016 May; 23(5):433-43. PubMed ID: 27080473
[TBL] [Abstract][Full Text] [Related]
16. The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas.
Leontiou CA; Gueorguiev M; van der Spuy J; Quinton R; Lolli F; Hassan S; Chahal HS; Igreja SC; Jordan S; Rowe J; Stolbrink M; Christian HC; Wray J; Bishop-Bailey D; Berney DM; Wass JA; Popovic V; Ribeiro-Oliveira A; Gadelha MR; Monson JP; Akker SA; Davis JR; Clayton RN; Yoshimoto K; Iwata T; Matsuno A; Eguchi K; Musat M; Flanagan D; Peters G; Bolger GB; Chapple JP; Frohman LA; Grossman AB; Korbonits M
J Clin Endocrinol Metab; 2008 Jun; 93(6):2390-401. PubMed ID: 18381572
[TBL] [Abstract][Full Text] [Related]
17. Mice with inactivation of aryl hydrocarbon receptor-interacting protein (Aip) display complete penetrance of pituitary adenomas with aberrant ARNT expression.
Raitila A; Lehtonen HJ; Arola J; Heliövaara E; Ahlsten M; Georgitsi M; Jalanko A; Paetau A; Aaltonen LA; Karhu A
Am J Pathol; 2010 Oct; 177(4):1969-76. PubMed ID: 20709796
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutations.
Jaffrain-Rea ML; Rotondi S; Turchi A; Occhi G; Barlier A; Peverelli E; Rostomyan L; Defilles C; Angelini M; Oliva MA; Ceccato F; Maiorani O; Daly AF; Esposito V; Buttarelli F; Figarella-Branger D; Giangaspero F; Spada A; Scaroni C; Alesse E; Beckers A
Endocr Relat Cancer; 2013 Oct; 20(5):753-66. PubMed ID: 23940012
[TBL] [Abstract][Full Text] [Related]
19. cAMP/PKA-induced filamin A (FLNA) phosphorylation inhibits SST2 signal transduction in GH-secreting pituitary tumor cells.
Peverelli E; Giardino E; Mangili F; Treppiedi D; Catalano R; Ferrante E; Sala E; Locatelli M; Lania AG; Arosio M; Spada A; Mantovani G
Cancer Lett; 2018 Oct; 435():101-109. PubMed ID: 30098401
[TBL] [Abstract][Full Text] [Related]
20. miR-34a is upregulated in AIP-mutated somatotropinomas and promotes octreotide resistance.
Bogner EM; Daly AF; Gulde S; Karhu A; Irmler M; Beckers J; Mohr H; Beckers A; Pellegata NS
Int J Cancer; 2020 Dec; 147(12):3523-3538. PubMed ID: 32856736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
